These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 2972431

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men.
    Faure N, Labrie F, Belanger A, Lemay A, Raynaud JP, Von der Ohe M, Fazekas AT.
    J Endocrinol Invest; 1982; 5(6):355-60. PubMed ID: 6820372
    [Abstract] [Full Text] [Related]

  • 47. Plasma levels of hydroxy-flutamide in patients with prostatic cancer receiving the combined hormonal therapy: an LHRH agonist and flutamide.
    Bélanger A, Giasson M, Couture J, Dupont A, Cusan L, Labrie F.
    Prostate; 1988; 12(1):79-84. PubMed ID: 3279409
    [Abstract] [Full Text] [Related]

  • 48. Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
    Tremblay Y, Bélanger A, Labrie F, Frenette G, Dubé JY, Tremblay RR.
    Prostate; 1984; 5(6):631-8. PubMed ID: 6208541
    [Abstract] [Full Text] [Related]

  • 49. Advances in the treatment of metastatic prostatic cancer.
    Elder JS, Gibbons RP.
    West J Med; 1985 Sep; 143(3):342-5. PubMed ID: 2413632
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C, Martínez de Osaba MJ, Martínez S, Fortuny A.
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin.
    Belanger A, Auclair C, Seguin C, Kelly PA, Labrie F.
    Mol Cell Endocrinol; 1979 Jan; 13(1):47-53. PubMed ID: 221286
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 57. Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man.
    Ruokonen A, Alén M, Bolton N, Vihko R.
    J Steroid Biochem; 1985 Jul; 23(1):33-8. PubMed ID: 3160892
    [Abstract] [Full Text] [Related]

  • 58. Role of adrenal androgens in prostate regression in rats treated with an antiandrogen and an LHRH agonist.
    Foldesy RG, Vanderhoof MM, Canton LE, Hahn DW.
    Prostate; 1986 Jul; 9(3):227-35. PubMed ID: 3534825
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.